Effectiveness and acceptability of continuous glucose monitoring for type 2 Diabetes management: a narrative review.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
hyperglycemia 1 endocrinologydiseases
hypoglycemia 3 endocrinologydiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
hyperglycemia 22633 (SD) SMBGL 57.5 ± 9 (SD) RT‐CGM 11.7 ± 5.8 (SD) SMBGL 13.3 ± 4.9 (SD) 12RT‐CGM ‐ with hyperglycemia counselingSMBGL + usual care†HbA1c (%):−1.1 vs −0.4 (P = 0.004)Change Weight (kg): −2.2
hypoglycemia 35284 levels34.DiscussionContinuous glucose monitoring has a potential role in limiting the frequency and/or onset of hypoglycemia in type 2 diabetes patients, particularly for those receiving insulin therapy, who have a history of
hypoglycemia 35405 2 diabetes patients, particularly for those receiving insulin therapy, who have a history of severe hypoglycemia or with irregular routines (skipping meals, vigorous exercise and poor sleep patterns)8, 21, 36, 37,
hypoglycemia 49441 these populations. Individuals requiring insulin for glycemic control might experience greater risk of hypoglycemia using CGM when compared with their non‐insulin‐taking counterparts. Therefore, larger, controlled

You must be authorized to submit a review.